¿µ±¸Çü ½É¹Úµ¿±â »ðÀÔ ÈÄ À¯ÀÇÇÑ »ï÷ÆÇ ¿ª·ùÁõ ¹ß»ýÀÇ ¿¹ÃøÀÎÀÚ
Predictors of the Development of Significant Tricuspid Regurgitation after Permanent Pacemaker Implantation
´ëÇѳ»°úÇÐȸÁö 2014³â 86±Ç 5È£ p.577 ~ p.584
ÀÌ°æÁø(Lee Kyoung-Jin) - Àü³²´ëÇб³º´¿ø ¼øȯ±â³»°ú
±è°èÈÆ(Kim Kye-Hun) - Àü³²´ëÇб³º´¿ø ¼øȯ±â³»°ú
ÀÓÀ̶û(Yim Yi-Rang) - Àü³²´ëÇб³º´¿ø ¼øȯ±â³»°ú
¹ÚÇõÁø(Park Hyuk-Jin) - Àü³²´ëÇб³º´¿ø ¼øȯ±â³»°ú
À̽ÂÇå(Lee Seung-Hun) - Àü³²´ëÇб³º´¿ø ¼øȯ±â³»°ú
±èÁöÀº(Kim Ji-Eun) - Àü³²´ëÇб³º´¿ø ¼øȯ±â³»°ú
Á¤Çü±â(Jeong Hyung-Ki) - Àü³²´ëÇб³º´¿ø ¼øȯ±â³»°ú
À±ÇöÁÖ(Yoon Hyun-Ju) - Àü³²´ëÇб³º´¿ø ¼øȯ±â³»°ú
À±³²½Ä(Yoon Nam-Sik) - Àü³²´ëÇб³º´¿ø ¼øȯ±â³»°ú
È«¿µÁØ(Hong Young-Joon) - Àü³²´ëÇб³º´¿ø ¼øȯ±â³»°ú
¹ÚÇü¿í(Park Hyung-Wook) - Àü³²´ëÇб³º´¿ø ¼øȯ±â³»°ú
±èÁÖÇÑ(Kim Ju-Han) - Àü³²´ëÇб³º´¿ø ¼øȯ±â³»°ú
¾È¿µ±Ù(Ahn Young-Keun) - Àü³²´ëÇб³º´¿ø ¼øȯ±â³»°ú
Á¤¸íÈ£(Jeong Myoung-Ho) - Àü³²´ëÇб³º´¿ø ¼øȯ±â³»°ú
Á¶Á¤°ü(Cho Jeong-Gwan) - Àü³²´ëÇб³º´¿ø ¼øȯ±â³»°ú
¹ÚÁ¾Ãá(Park Jong-Chun) - Àü³²´ëÇб³º´¿ø ¼øȯ±â³»°ú
Abstract
Background/Aims: We sought to identify predictors of significant tricuspid regurgitation (TR) after successful permanent pacemaker (PPM) implantation in Korean patients.
Method: Of 404 patients who underwent PPM implantation, 187 patients who had both baseline and follow-up echocardiographic examinations were assigned to one of two groups: no development or change in TR (Group I, n = 172, 65.5 ¡¾ 13.7 years) versus the development of significant TR (Group II, n = 15, 72.1 ¡¾ 8.3 years). Clinical, laboratory, and echocardiographic variables were compared between the two groups.
Results: Overall, the grade of TR was significantly aggravated from 0.46 ¡¾ 0.73 to 0.81 ¡¾ 0.84 (p < 0.001) during 3.1 ¡¾ 1.8 years of follow-up (0.49 ¡¾ 0.75 to 0.69 ¡¾ 0.74 in Group I, p < 0.001; 0.13 ¡¾ 0.35 to 2.27 ¡¾ 0.46 in Group II, p < 0.001). The de novo development or aggravation of TR was observed in 66 patients (35.3%), and significant TR developed in 15 patients (8.0%). The presence of atrial fibrillation (AF) was significantly higher (53.3 vs. 18.6%, p = 0.002), and the implantation of a ventricle pacing, ventricle sensing, inhibited by ventricular event (VVI) type pacemaker was more frequent in Group II than in Group I (46.7 vs. 15.1%, p = 0.002). Other variables were not different between the groups.
Conclusions: The development or aggravation of TR was not rare after successful PPM implantation, even though the development of significant TR was uncommon. The presence of AF and the implantation of a VVI type pacemaker were predictors of the development of significant TR. Together, the results of this study suggest that the development or aggravation of TR should be monitored carefully after PPM implantation.
Å°¿öµå
Pacemaker, Tricuspid valve insufficiency, Atrial fibrillation
KMID :
0882420140860050577
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)